Dow Down 0.32% Nasdaq Down 0.62%

Trevena, Inc. (TRVN)

-NasdaqGS
7.79 Down 0.17(2.14%) Apr 29, 4:00PM EDT
|After Hours : 7.79 0.00 (0.00%) Apr 29, 4:41PM EDT
Prev Close:7.96
Open:8.10
Bid:7.73 x 1000
Ask:8.75 x 1000
1y Target Est:15.75
Beta:N/A
Earnings Date:May 5 - May 9 (Est.)
Day's Range:7.66 - 8.18
52wk Range:5.06 - 13.57
Volume:377,090
Avg Vol (3m):467,346
Market Cap:406.41M
P/E (ttm):N/A
EPS (ttm):-1.26
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for TRVN

Comparison

Symbol% ChgMkt Cap
TRVNDown 2.14%406.41M
CYTKDown 1.45%322.40M

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):92.37
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-16) :-0.61
Quarterly EPS Est (Mar-16) :-0.32
Mean Recommendation*:1.6
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Trevena, Inc., a clinical stage biopharmaceutical company, discovers, develops, and intends to commercialize therapeutics for G protein coupled receptors. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback